These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11257709)
21. Molecular targets of 1,25(OH)2D3 in HC11 normal mouse mammary cell line. Katayama ML; Pasini FS; Folgueira MA; Snitcovsky IM; Brentani MM J Steroid Biochem Mol Biol; 2003 Jan; 84(1):57-69. PubMed ID: 12648525 [TBL] [Abstract][Full Text] [Related]
22. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells. Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613 [TBL] [Abstract][Full Text] [Related]
23. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Scharla SH; Strong DD; Mohan S; Baylink DJ; Linkhart TA Endocrinology; 1991 Dec; 129(6):3139-46. PubMed ID: 1720089 [TBL] [Abstract][Full Text] [Related]
24. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines. Sugibayashi R; Kiguchi Y; Shimizu T; Suzuki T; Hamada H; Takeda K Anticancer Res; 2002; 22(2A):713-9. PubMed ID: 12014641 [TBL] [Abstract][Full Text] [Related]
25. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. Miyake H; Pollak M; Gleave ME Cancer Res; 2000 Jun; 60(11):3058-64. PubMed ID: 10850457 [TBL] [Abstract][Full Text] [Related]
26. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Rashid SF; Moore JS; Walker E; Driver PM; Engel J; Edwards CE; Brown G; Uskokovic MR; Campbell MJ Oncogene; 2001 Apr; 20(15):1860-72. PubMed ID: 11313934 [TBL] [Abstract][Full Text] [Related]
27. Regulation of proliferation of prostate epithelial cells by 1,25-dihydroxyvitamin D3 is accompanied by an increase in insulin-like growth factor binding protein-3. Sprenger CC; Peterson A; Lance R; Ware JL; Drivdahl RH; Plymate SR J Endocrinol; 2001 Sep; 170(3):609-18. PubMed ID: 11524241 [TBL] [Abstract][Full Text] [Related]
28. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3. Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112 [TBL] [Abstract][Full Text] [Related]
29. p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells. Polek TC; Stewart LV; Ryu EJ; Cohen MB; Allegretto EA; Weigel NL Endocrinology; 2003 Jan; 144(1):50-60. PubMed ID: 12488329 [TBL] [Abstract][Full Text] [Related]
30. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors. Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944 [TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. Rajah R; Lee KW; Cohen P Cell Growth Differ; 2002 Apr; 13(4):163-71. PubMed ID: 11971816 [TBL] [Abstract][Full Text] [Related]
32. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice. Shukla S; Mishra A; Fu P; MacLennan GT; Resnick MI; Gupta S FASEB J; 2005 Dec; 19(14):2042-4. PubMed ID: 16230333 [TBL] [Abstract][Full Text] [Related]
33. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2. Bauer JA; Thompson TA; Church DR; Ariazi EA; Wilding G Prostate; 2003 May; 55(3):159-67. PubMed ID: 12692781 [TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells. Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406 [TBL] [Abstract][Full Text] [Related]
35. 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1). Huang J; Yang G; Huang Y; Kong W; Zhang S Mol Med Rep; 2016 Feb; 13(2):1373-80. PubMed ID: 26676829 [TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor binding protein-3 modulates osteoblast differentiation via interaction with vitamin D receptor. Li J; Jin D; Fu S; Mei G; Zhou J; Lei L; Yu B; Wang G Biochem Biophys Res Commun; 2013 Jul; 436(4):632-7. PubMed ID: 23770368 [TBL] [Abstract][Full Text] [Related]